2Fujita M, Enomoto T, Murata Y. Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes [J].Mol Cell Endocrinol, 2003,202( 1 -2) :97 -99.
3Garrett A P, Lee K R, Colitti C R, et al. K-ras mutation may be an early event in mucinous ovarian tumorigenesis[J]. Int J Gynecol Pathol, 2001,20(3) :244 -251.
4Semczuk A, Postawski K, Przadka D, et al. K-ras gene point mutations and p21 ras immunostaining in human ovarian tumors [J].Eur J Gynaecol Oncol, 2004,25 (4) :484 -488.
5Fauvet R,Dufoumet C, Poncelet C, et al. Expression of pro-apoptotic (.p53, p21, bax, bak and fas) and anti-apoptotic ( bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours [ J ]. J Surg Oncol, 2005,92 (4) :337 - 343.
6Sui L, Dong Y, Ohno M, et al. Inverse expression of Cdk4 and p16 in epithelial ovarian tumors [ .I ]. Gynecol Oncol, 2000,79(2) :230 -237.
7McCluskey L L, Chen C, Delgadillo E,et al. Differences in p16 gene methylation and expression in benign and malignant ovarian tumors [ J ]. Gynecol Oncol, 1999,72 ( 1 ) :87 - 92.
8Havrilesky L J, Alvarez A A, Whitaker R S, et al. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations[J]. Gynecol Oncol, 2001,83(3) :491 -500.
10Albarracin C T,Jafri J, Montag A G,et al. Differential expression of MUC2 and MUCSAC mucin genes in primary ovarian and metastatic colonic carcinoma [J]. Hum Patho1,2000,31 (6) :672 - 677.
2Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a ras association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet, 2000,25:315-319.
3Wistuba I, Behrens C, Virmani AK, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res, 2000,60: 1949-1960.
4Kok K, Naylor SL, Buys CH. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res,1997, 71:27-92.
5Hung J, Kishimoto Y, Sugio K, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma.JAMA, 1995,273 : 558-563.
6Sekido Y, Ahmadian M, Wistuba II, et al. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene. Oncogene, 1998,16:3151-3157.
7Lee MG, Kim HY, Byun DS, et al. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Res, 2001,61:6688-6692.
8Byun DS, Lee MG, Chae KS, et al. Frequent epigenetic inactivation of RASSFIA by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res, 2001, 61: 7034-7038.
9Burbee DG, Forgacs E, Zochbauer-Muller S, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Nat Cancer Inst, 2001,93 : 691-699.
10Vos MD, Ellis CA, Bell A, et al. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem, 2000,275:35669-35672.
2Gadducci A,Cosio S,Gargini A.Sex-steroid hormones,gonadotropin and ovarian carcinogenesis:a review of epidemiological and experimental data[J].Gynecol Endocrinol,2004,19(4):216-228.
3Matzuk M M,Finegold M J,Su J G,et al.α-inhibin is a tumour-suppressor gene with gonadal specificity in mice[J].Nature,1992,360(6402):313-319.
4Choi K C,Kang S K,Nathwani P S,et al.Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE)[J].Mol Cell Endocrinol,2001,174(1-2):99-110.
5Zheng W,Luo M P,Welt C,et al.Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer[J].Gynecol Oncol,1998,69(1):23-31.
6Florio P,Ciarmela P,Tiso E,et al.α-inhibin and the inhibin corecepter β-glycan are downregulated in endometrial carcinoma[J].Eur J Endocrinol,2005,152(2):277-284.
7Mellor S L,Richards M G,Pedersen J S,et al.Loss of the expression and localization of α-inhibin subunit in high grade prostate cancer[J].J Clin Endocrinol Metab,1998,83(3):969-975.
8Wang X F,Lin H Y,Ng E E,et al.Expression cloning and characterization of the TGF-β-type Ⅲ receptor[J].Cell,1991,67(4):797-805.
9Gray P C,Bilezikjian L M,Vale W.Antagonism of activin by inhibin and inhibin receptors:a functional role for β-glycan-glycan[J].Mol Cell Endocrinol,2001,180(1-2):47-53.
10Lewis K A,Gray P C,Blount A L,et al.β-glycan binds inhibin and can mediate functional antagonism of activin signalling[J].Nature,2000,404(6776):411-414.
